ArticleMedicine2025
Association between new dietary index for gut microbiota and lung cancer: A population-based study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The dietary index for gut microbiota (DI-GM), which reflects microbiota diversity, has not yet been linked to lung cancer. To explore this, we analyzed the relationship between DI-GM and lung cancer using data from the National Health and Nutrition Examination Survey. This analysis used National Health and Nutrition Examination Survey data from 2007 to 2018. We assessed multicollinearity among the independent variables with variance inflation factors, then performed weighted logistic regression, subgroup analysis, and applied a restricted cubic spline model to explore the relationship between DI-GM and lung cancer. The study included 22,473 adults aged 20 and older. The adjusted findings indicated that a higher DI-GM was associated with a reduced likelihood of lung cancer. variance inflation factors confirmed the absence of multicollinearity. After adjusting for potential confounders, participants with the highest DI-GM had a 72% lower risk of developing lung cancer compared to those with the lowest scores (OR = 0.28; 95% CI: 0.09-0.84, P = .02). A linear negative correlation was observed between DI-GM and the risk of lung cancer. This cross-sectional investigation revealed a negative relationship between the DI-GM and the likelihood of lung cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.